Clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics

Sectors
Healthcare
Life Sciences
First Invested
2009
Public/PIPES
Company Status
IPO/Acquired
NASDAQ: VIRX
Merger between Sunesis and Viracta
Associated Team
Paul Walker